After 104 weeks of treatment, the primary outcome of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke occurred in 6.6% of the patients in the semaglutide group and 8.9% of those in the placebo group, resulting in a hazard ratio (HR) of 0.74 (95% CI 0.580.95) [13]
We bring you expertise in preclinical studies, including custom diet-induced obesity (DIO) and other modified models
Participants in the SGLT2i group were less likely to require admission to hospital for any reason than those in the GLP-1 RA group (RR 0.59 [95% CI 0.46, 0.76] p 0.0001)
Patients can also use the contact page to ask about next steps
Delivery timings are between 10am and 5pm on Mondays to Fridays, and 10am to 12pm on Saturdays (No delivery on Sundays and Public Holidays)
We invite you to take the next step by contacting our team for a personalized consultation and to explore the potential of adding L-Carnitine 500mg to your product offerings